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The role of private providers in maternal health
Every day, nearly 800 women die from complications 
of pregnancy and childbirth. A great many of these 
deaths are preventable; however, there is no single, 
straightforward solution. Because identiﬁ cation of every 
woman who will have a life-threatening complication 
during pregnancy or childbirth is impossible, saving 
of women’s lives during pregnancy and childbirth 
needs a systems approach with on-call structures in 
place that can respond immediately and eﬀ ectively to 
these complications, around the clock. This challenge is 
daunting for most of the countries where the burden of 
maternal mortality is highest, but should not paralyse 
action. To accelerate progress to reach Millennium 
Development Goal 5, health systems should bring 
solutions to the women who need them most, and make 
these solutions sustainable at adequate scale.
Private health care is one of the fastest growing 
segments of the health-care system, and private 
providers (ie, all non-public-sector providers) and 
businesses (ie, pharmacies) are an important source of 
health care for families in the lower wealth quintiles in 
low-income and middle-income countries.1 In countries 
such as Nigeria and Uganda, more than 50% of the 
population in the lowest income bracket seek health 
services from private health workers (eg, licensed and 
unlicensed providers, midwives, pharmacists, and 
traditional healers).2 Although these locally based 
providers are often the ﬁ rst line of response for families in 
need of health care, little is known about the services they 
provide, the quality of their care, or the fees they charge. 
Private providers attend deliveries both at homes and in 
medical facilities, constituting a substantial proportion of 
delivery services in some low-income and middle-income 
countries.3 Additionally, for many years the private sector 
has played a substantial part in provision of services 
for family planning, one of the most eﬀ ective ways to 
reduce maternal mortality.3–6 Recent evidence from social 
franchising suggests that this model of clinical service 
delivery by private providers is positively associated with 
client volume, client satisfaction, and in some instances 
increased use of services and positive health eﬀ ects.7 
However, questions about equity and cost-eﬀ ectiveness 
need further research.7 Whether the private sector can 
have a key role in prevention of maternal mortality is an 
essential question.
So far, the development and donor community has 
largely focused its eﬀ orts on strengthening of the public 
health sector, despite the potentially substantial part 
the private sector could play to address maternal health. 
The potential role of the private sector as a contributor 
to achieve Millennium Development Goal 5 should be 
explored, not ignored. To do so, more data and analyses 
are needed to understand the private sector’s size and 
importance in maternal health, including how many 
private providers and facilities oﬀ ering services for 
maternal care exist (and where), who the private sector 
reaches with these services, what services are oﬀ ered, 
and what is the content and quality of care. Other key 
questions include why some services are sought in the 
private setting rather than public settings; to what 
extent private providers ﬁ ll gaps in public services; 
whether the private sector relieves any burden on the 
public sector; whether provision of consistent high-
quality care by private providers can be sustainably 
ensured; whether private providers subsidise or exploit 
the poor; to what degree private-sector models promote 
or diminish equity; and how the public and private 
sectors can be linked eﬀ ectively for referral, transport, 
and management of human resources for health.
Robust studies of private-care models are needed 
to answer these key questions. Very few well designed 
studies about the successes or failures of private-sector 
models in maternal health (eg, franchising, especially for 
labour and delivery services) have been reported.3 To that 
end, Merck for Mothers will test various approaches for 
private care in countries with a high burden of maternal 
mortality (eg, Uganda, Senegal, and India). The overall 
goals of Merck for Mothers is to address the two leading 
causes of maternal mortality: postpartum haemorrhage 
(bleeding after childbirth) and pre-eclampsia and 
eclampsia (hypertensive disorders of pregnancy), as 
well as family planning. Merck for Mothers is a 10-year 
US$500 million initiative that will assess its programmes 
in partnership with the London School of Hygiene 
and Tropical Medicine to address some of these key 
questions. However, many more such eﬀ orts are needed.
The private sector’s potential contribution to address 
maternal mortality cannot be ignored. Growth of 
the private sector in health could be an important 
opportunity to tackle maternal mortality. To do so, the 
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specialty needs to invest in expanding of the knowledge 
base for the role and eﬀ ectiveness of private care to 
increase access to aﬀ ordable high-quality maternal care. 
Global progress towards achievement of Millennium 
Development Goal 5 could depend on this eﬀ ort.
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